Multi-centre, oral single dose experimental and modelling study to evaluate the pharmacokinetics of deferiprone in patients aged from 1 month to less than 6 years of age affected by transfusion-dependent haemoglobinopathies

Trial Profile

Multi-centre, oral single dose experimental and modelling study to evaluate the pharmacokinetics of deferiprone in patients aged from 1 month to less than 6 years of age affected by transfusion-dependent haemoglobinopathies

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jan 2017

At a glance

  • Drugs Deferiprone (Primary)
  • Indications Iron overload
  • Focus Pharmacokinetics
  • Acronyms DEEP-1
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Sep 2016 Results Results assessing population pharmacokinetics and dosing recommendations published in the British Journal of Clinical Pharmacology
    • 21 Jun 2014 Status changed from recruiting to completed, as per European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top